Search

Your search keyword '"Dongiovanni, Paola"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Dongiovanni, Paola" Remove constraint Author: "Dongiovanni, Paola" Journal journal of hepatology Remove constraint Journal: journal of hepatology
123 results on '"Dongiovanni, Paola"'

Search Results

1. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

2. TOP-301 Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in steatotic liver disease

5. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

6. Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19]

7. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

8. Metabolic associated fatty liver disease: different impact of the three defining criteria on the hepatic and cardiovascular complications

9. The PNPLA3 I148M variant aggravates inflammation through dysfunctional LXR and PPAR gamma signalling in macrophages

10. The PNPLA3 I148M variant initiates metabolic reprogramming in macrophages

11. Programmed cell death 1 genetic variant and liver damage in non-alcoholic fatty liver disease

12. Combined hepatic and adipose tissue transcriptomics highlights circulating NASH biomarkers

16. A functional interaction between hepatic estrogen receptor-α and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women

17. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

18. Statin use and non-alcoholic steatohepatitis in at risk individuals

19. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

20. Comparison of hepatic and cardiovascular damage between HIV patients with steatosis and NAFLD: role of metabolic alterations and low visceral adiposity

22. Increased burden of inherited IRF3 rare genetic variants in Europeans with severe Non-alcoholic fatty liver diease

24. SIRT5 rs12216101 T > G variant is associated with mitochondrial dysfunction and disease severity in patients with NAFLD

26. The different modulation of KLB expression impacts on liver damage in NAFLD patients and in an in vitro model: a novel druggable target?

27. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD

28. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

29. WED-549 - Programmed cell death 1 genetic variant and liver damage in non-alcoholic fatty liver disease

37. THU-461 - Metabolic associated fatty liver disease: different impact of the three defining criteria on the hepatic and cardiovascular complications

40. A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification

41. Validation of interleukin-32 as a new circulating fatty liver biomarker

42. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in people with hereditary haemochromatosis

43. β-Klotho gene variation is associated with liver damage in children with NAFLD

47. PS-006-MBOAT7 downregulation induces hepatic lipid accumulation

48. FRI-333-ATG7 genetic variant and defective autophagy: A novel risk factor for non-alcoholic fatty liver disease progression in patients with type 2 diabetes mellitus

49. SAT-275-Interleukin-32 as a novel NAFLD biomarker in PNPLA31148M variant carriers

50. THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes

Catalog

Books, media, physical & digital resources